Literature DB >> 31523141

Cognitive Functioning and Silent Neurological Manifestations in Behçet's Disease with Ocular Involvement.

Yavuz Altunkaynak1, Şebnem Usta1, Devrimsel Harika Ertem2, Ayhan Köksal1, Ayten Ceyhan Dırıcan1, Sevim Baybaş1.   

Abstract

INTRODUCTION: Various reports have revealed a cognitive dysfunction in Behçet's disease (BD). In this study, we aimed to assess the silent neurological manifestations, behavioral and neuropsychiological impairments of Behçet's disease patients with ocular involvement.
METHODS: Thirty BD patients with ocular involvement in the nonactive phase of their illness were applied detailed neurological examination and magnetic resonance imagining (MRI). Neuropsychological tests were performed. Patients' neuropsychological performances were compared to those of healthy, demographically matched twenty subjects.
RESULTS: Neurological manifestations of patients were headache (56.6%), pyramidal signs (13.3%), behavioral changes (3.3%) and sensory symptoms (3.3%). Four patients (13.3%) had white matter hyperintensities lesions on T2/FLAIR brain MRI. Fourteen patients (46%) had impaired cognitive performances on the following tasks: verbal memory (immediate memory p=0.000, maximal learning capacity p=0.009, number of repetitions p=0.000, total learning capacity p=0.001, recall p=0.033), nonverbal memory (immediate memory p=0.029, recall p=0.001), logical memory (immediate memory p=0.001, recall p=0.001), executive (frontal) functions (clock-drawing test p=0.000, Stroop test p=0.001, verbal fluency tests p=0.000). Patients' MMSE and clock drawing test scores were significantly lower than controls (p=0.03). Attention deficit was not detected. Behçet's disease patients showed higher scores on depression scales than healthy subjects but there was no statistically significant difference between anxiety scores.
CONCLUSION: Neuropsychological deficits, involving mainly memory and executive functioning, subcortical MRI lesions, and non-structural headache may be present in Behçet's disease patients with ocular involvement without overt neurological manifestations.

Entities:  

Keywords:  Behçet’s disease; cognitive impairment; headache; neuropsychology; uveitis

Year:  2018        PMID: 31523141      PMCID: PMC6732813          DOI: 10.5152/npa.2017.19406

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  24 in total

1.  Prevalence of Behçet's disease in Istanbul, Turkey.

Authors:  Gülsevim Azizlerli; Afet Akdağ Köse; Rifkiye Sarica; Ahmet Gül; Ilknur Tuğal Tutkun; Mustafa Kulaç; Recep Tunç; Meri Urgancioğlu; Rian Dişçi
Journal:  Int J Dermatol       Date:  2003-10       Impact factor: 2.736

2.  P300 and neuropsychological evaluation in Behçet's disease with and without neurological manifestations.

Authors:  Figen Gökçay; Neşe Celebisoy; Ayşin Kisabay; Emre Kumral; Onder Akyürekli
Journal:  J Neurol       Date:  2004-06       Impact factor: 4.849

3.  Cognitive event-related potential and neuropsychological findings in Behcet's disease without neurological manifestations.

Authors:  Handan Isin Ozisik; Rifat Karlidag; Ersoy Hazneci; Sibel Kizkin; Cemal Ozcan
Journal:  Tohoku J Exp Med       Date:  2005-05       Impact factor: 1.848

Review 4.  Cognitive deficits in depression: possible implications for functional neuropathology.

Authors:  M P Austin; P Mitchell; G M Goodwin
Journal:  Br J Psychiatry       Date:  2001-03       Impact factor: 9.319

5.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

6.  Behçet's syndrome: a multidisciplinary approach to clinical care.

Authors:  A J Whallett; G Thurairajan; J Hamburger; R G Palmer; P I Murray
Journal:  QJM       Date:  1999-12

7.  Neuropsychological follow-up of 12 patients with neuro-Behçet disease.

Authors:  O Oktem-Tanör; B Baykan-Kurt; I H Gürvit; G Akman-Demir; P Serdaroğlu
Journal:  J Neurol       Date:  1999-02       Impact factor: 4.849

8.  Headache in Behçet's syndrome.

Authors:  Sabahattin Saip; Aksel Siva; Ayse Altintas; Asli Kiyat; Emire Seyahi; Vedat Hamuryudan; Hasan Yazici
Journal:  Headache       Date:  2005 Jul-Aug       Impact factor: 5.887

9.  Cognitive impairment in Behçet's disease patients without overt neurological involvement.

Authors:  Roberto Monastero; Cecilia Camarda; Carmela Pipia; Gianluca Lopez; Lawrence K C Camarda; Valentina Baiamonte; Angelo Ferrante; Giovanni Triolo; Rosolino Camarda
Journal:  J Neurol Sci       Date:  2004-05-15       Impact factor: 3.181

10.  The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center.

Authors:  Emire Kural-Seyahi; Izzet Fresko; Nurhan Seyahi; Yilmaz Ozyazgan; Cem Mat; Vedat Hamuryudan; Sebahattin Yurdakul; Hasan Yazici
Journal:  Medicine (Baltimore)       Date:  2003-01       Impact factor: 1.889

View more
  2 in total

1.  Risk of anxiety and depression in patients with uveitis: a Meta-analysis.

Authors:  Bei Cui; Hong-Zhen Jia; Li-Xiong Gao; Xiao-Fei Dong
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

Review 2.  Treating the Different Phenotypes of Behçet's Syndrome.

Authors:  Alessandra Bettiol; Gulen Hatemi; Lorenzo Vannozzi; Alessandro Barilaro; Domenico Prisco; Giacomo Emmi
Journal:  Front Immunol       Date:  2019-12-06       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.